DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
DOVA
Delisted
DOVA was delisted on the 11th of November, 2019.
59 hedge funds and large institutions have $75.9M invested in Dova Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 16
Holders
59
Holding in Top 10
–
Calls
$804K
Puts
$126K
Top Buyers
| 1 | +$2.51M | |
| 2 | +$1.76M | |
| 3 | +$1.25M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.05M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$631K |
Top Sellers
| 1 | -$2.67M | |
| 2 | -$2.12M | |
| 3 | -$1.4M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$327K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$168K |